Abbott Laboratories discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Established Pharmaceutical, Diagnostic, Nutritional, and Medical Devices segments, with brands like FreeStyle Libre and Ensure.
Abbott Laboratories operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ABT.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ABT Stock Intelligence Report. [stoxpulse.com/stocks/abt]
Disclaimer: The information on this page about Abbott Laboratories (ABT) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Abbott Laboratories.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings miss
Mar 31
STARKS bought 10K shares
Apr 27
Conroy bought 2K shares
Apr 24
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade ...
12h ago
Cardiac Monitoring & Rhythm Management Devices Mar...
12h ago
StoxPulse AI results for ABT: Pulse Score 53/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$159.31B
P/E Ratio
33.6
EPS
$1.02
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
-0.6%
Sep 25
-1.1%
Dec 25
-0.7%
Mar 26
-0.5%
Beat estimates 0 of 4 quarters (0%)
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Established Pharmaceutical, Diagnostic, Nutritional, and Medical Devices segments, with brands like FreeStyle Libre and Ensure.
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)?
Cardiac Monitoring & Rhythm Management Devices Market by Type, Application, End User - Global Forecast to 2031
Abbott Addresses a Major Diabetes Care Gap With Tech Innovation
Jim Cramer Says “No One Disputes the Science and Commercial Smarts of Abbott”
Assessing Abbott Laboratories (ABT) Valuation After New Diabetes Sensor And Cancer Screening Tailwinds
Medtronic Stock Is Defying a Market Selloff After Earnings. Here’s Why.
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
MiniMed expands Abbott partnership to add dual glucose-ketone sensor